SJS Investment Consulting’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$39.8K	Buy	705 +126	+22%	+$7.35K	﹤0.01%	468
2025 Q4	$34.4K	Buy	579 +566	+4,354%	+$30.8K	﹤0.01%	477
2025 Q3	$705	Buy	+13	New	+$743	﹤0.01%	1119
2025 Q2	–	Sell	-21	Closed	-$1.49K	–	1569
2025 Q1	$1.49K	Buy	21 +17	+425%	+$1.14K	﹤0.01%	852
2024 Q4	$263	Sell	4 -24	-86%	-$1.61K	﹤0.01%	1422
2024 Q3	$1.97K	Buy	28 +10	+56%	+$836	﹤0.01%	793
2024 Q2	$1.48K	Sell	18 -1	-5%	-$83	﹤0.01%	865
2024 Q1	$1.66K	Buy	19 +3	+19%	+$269	﹤0.01%	833
2023 Q4	$1.54K	Sell	16 -6	-27%	-$531	﹤0.01%	776
2023 Q3	$1.95K	Buy	22 +2	+10%	+$178	﹤0.01%	643
2023 Q2	$1.73K	Buy	20 +6	+43%	+$565	﹤0.01%	662
2023 Q1	$1.36K	Sell	14 -9	-39%	-$933	﹤0.01%	747
2022 Q4	$2.38K	Buy	23 +10	+77%	+$939	﹤0.01%	556
2022 Q3	$1K	Buy	+13	New	+$1.16K	﹤0.01%	632
2022 Q1	$0	Buy	+3	New	+$251	﹤0.01%	755